Wendy future of retail top

PMC: Personalized medicines topped 25% of new drug approvals

PMC: Personalized medicines topped 25% of new drug approvals

PMC: Personalized medicines topped 25% of new drug approvals

WASHINGTON  — The Personalized Medicine Coalition (PMC) today released a report showing that personalized medicines designed for subpopulations of patients with certain biological characteristics accounted for 34% of the U.S. Food and Drug Administration (FDA)’s new drug approvals in 2022 and have accounted for at least 25% of approvals for each of the last eight years.

Centrum 7/6  banner